Subscribe to RSS
DOI: 10.1055/a-2716-4930
Pulmonary Alveolar Microlithiasis: A Review of a Rare Disease Through Rarely Discussed Perspectives
Authors
Abstract
Pulmonary alveolar microlithiasis (PAM) has been well characterized in terms of its description, genetic background, and diagnostic process for decades; however, no effective prevention or treatment has yet been established. PAM is classified as an ultrarare lung disease linked to mutations in the autosomal recessive sodium–phosphate co-transporter gene SLC34A2, which may serve as a potential target for future therapies. As new variants of SLC34A2 mutations continue to be identified, a broader genetic understanding could help predict the variable clinical course among patients and guide the development of therapies beyond palliative care. The creation of a disease severity score would be valuable for assessing disease burden, stratifying patients, and designing research studies. Given the clinico-radiological dissociation and heterogeneity of PAM, such a score should be developed as a composite index. Coupled with objective severity measures and identification of factors underlying individual variability, this approach could enhance insight into preventive and therapeutic strategies. Clinical advances in PAM remain limited, underscoring the need for international registries and cohorts as an urgent priority. Systematic re-evaluation of diagnosed cases and structured follow-up, rather than arbitrary visits, would generate standardized data critical for future research. A standardized patient evaluation form may facilitate the collection of data in a shared database.
Keywords
pulmonary alveolar microlithiasis - pathogenesis - lung transplantation - treatment - registry - future perspectivePublication History
Received: 11 July 2025
Accepted: 03 October 2025
Article published online:
29 October 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Kosciuk P, Meyer C, Wikenheiser-Brokamp KA, McCormack FX. Pulmonary alveolar microlithiasis. Eur Respir Rev 2020; 29 (158) 200024
- 2 Shaw BM, Shaw SD, McCormack FX. Pulmonary alveolar microlithiasis. Semin Respir Crit Care Med 2020; 41 (02) 280-287
- 3 Castellana G, Castellana G, Gentile M, Castellana R, Resta O. Pulmonary alveolar microlithiasis: review of the 1022 cases reported worldwide. Eur Respir Rev 2015; 24 (138) 607-620
- 4 Malpighi M. Manoscritti, vol. XII, foglio 81. 1686
- 5 Puhr L. Mikrolithiasis alveolaris pulmonum. Virchows Arch Pathol Anat Physiol Klin Med 1933; 290: 156-160
- 6 Harbitz F. Extensive calcification of the lungs as a distinct disease. Arch Intern Med (Chic) 1918; 21 (01) 139-146
- 7 Erel F, Güngör C, Sarıoğlu N, Aksu GD, Turan G, Demirpolat G. Spontaneous pneumomediastinum and subcutaneous emphysema secondary to pulmonary alveolar microlithiasis. Tuberk Toraks 2021; 69 (03) 416-420
- 8 Helmink A, Atiya S, Martinez Duarte E. Pulmonary alveolar microlithiasis: a unique case of familial PAM complicated by transplant rejection. Case Rep Pathol 2021; 2021: 6674173
- 9 Günther G, Einbeck C. Pulmonary alveolar microlithiasis complicated by tuberculosis. N Engl J Med 2021; 384 (10) e36
- 10 Liu Q, Ju X, Guo T, Peng H. A novel compound heterozygous mutation in the SLC34A2 gene causes pulmonary alveolar microlithiasis. QJM 2024; 117 (04) 293-296
- 11 Ufuk F. Pulmonary alveolar microlithiasis. Radiology 2021; 298 (03) 567
- 12 Li WZ, Liu S, Luo JL, Xia J. Pulmonary alveolar microlithiasis combined with gastric mucosal calcification: a case report. Front Med (Lausanne) 2024; 11: 1357260
- 13 Buschulte K, Cottin V, Wijsenbeek M, Kreuter M, Diesler R. The world of rare interstitial lung diseases. Eur Respir Rev 2023; 32 (167) 220161
- 14 Cueto-Robledo G, Cantero-Ceballos MD, Gonzalez-Hermosillo LM. et al. Severe pulmonary hypertension in pulmonary alveolar microlithiasis: a comprehensive literature review. Curr Probl Cardiol 2024; 49 (05) 102453
- 15 Jönsson ALM, Hilberg O, Simonsen U, Christensen JH, Bendstrup E. New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review. Orphanet J Rare Dis 2023; 18 (01) 130
- 16 Batesh D, Habash R, Alhaffar MN, Almani I. Pulmonary alveolar microlithiasis: a rare case report from Syria. Ann Med Surg (Lond) 2023; 85 (09) 4566-4569
- 17 Elgara M, Sulaiman TO, Hussein M, Al Langawi M. Exploring the silent storm. Qatar Med J 2024; 2024 (02) 3
- 18 Saito A, Nikolaidis NM, Amlal H. et al. Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment. Sci Transl Med 2015; 7 (313) 313ra181
- 19 Uehara Y, Tanaka Y, Zhao S. et al. Insights into pulmonary phosphate homeostasis and osteoclastogenesis emerge from the study of pulmonary alveolar microlithiasis. Nat Commun 2023; 14 (01) 1205
- 20 Saito A, McCormack FX. Pulmonary alveolar microlithiasis. Clin Chest Med 2016; 37 (03) 441-448
- 21 Enemark A, Jönsson ÅLM, Kronborg-White S, Bendstrup E. Pulmonary alveolar microlithiasis—a review. Yale J Biol Med 2021; 94 (04) 637-644
- 22 Bendstrup E, Jönsson ÅLM. Pulmonary alveolar microlithiasis: no longer in the stone age. ERJ Open Res 2020; 6 (03) 00289-02020
- 23 Ferreira Francisco FA, Pereira e Silva JL, Hochhegger B, Zanetti G, Marchiori E. Pulmonary alveolar microlithiasis. State-of-the-art review. Respir Med 2013; 107 (01) 1-9
- 24 Zhang M, Gao M, Liu Y. et al. Two novel gene mutations identified in a child with pulmonary alveolar microlithiasis complicated with bronchitis obliterans: a case report and literature review. Clin Case Rep 2023; 11 (08) e7726
- 25 Jönsson ÅL, Simonsen U, Hilberg O, Bendstrup E. Pulmonary alveolar microlithiasis: two case reports and review of the literature. Eur Respir Rev 2012; 21 (125) 249-256
- 26 Mar Conde MD, Ramírez LE, Morales EI, Sua LF, Trujillo LF. Pulmonary alveolar microlithiasis in a young man undergoing lung transplantation: a case report. Int J Surg Pathol 2025; 33 (02) 442-449
- 27 Van Luong H, Anh LV, Nguyen PT. Losing vigilance in diagnosing pulmonary alveolar microlithiasis: a report on four cases. J Clin Imaging Sci 2023; 13: 32
- 28 Castellana G, Castellana R, Fanelli C. et al. La microlitiasi alveolare polmonare: decorso clinico e radiologico, convenzionale e HRCT, in tre casi. Ipotesi di classificazione radiologica della malattia. Radiol Med 2003; 106: 160-168
- 29 Horvatić Herceg G, Bracić I, Korsić M. et al. “Sandstorm” image: bone scintigraphy in pulmonary alveolar microlithiasis. Eur J Nucl Med Mol Imaging 2009; 36 (08) 1353
- 30 Fallahi B, Ghafary BM, Fard-Esfahani A, Eftekhari M. Diffuse pulmonary uptake of bone-seeking radiotracer in bone scintigraphy of a rare case of pulmonary alveolar microlithiasis. Indian J Nucl Med 2015; 30 (03) 277-279
- 31 Nawawi YS, Soewondo W. A case report of pulmonary alveolar microlithiasis: focus on radiologic findings. Am J Case Rep 2023; 24: e938456
- 32 Jolobe OMP. Pulmonary alveolar microlithiasis and pulmonary tuberculosis. QJM 2021; 114 (07) 535
- 33 So C, Jinta T. Reply to Pulmonary alveolar microlithiasis and pulmonary tuberculosis. QJM 2021; 114 (07) 536
- 34 Sarkar M, Sharma SK, Jhobta A, Gulati A. A case report of pulmonary alveolar microlithiasis with pulmonary tuberculosis. Lung India 2023; 40 (02) 161-164
- 35 Tendolkar MS. An “Orphan” in search of a treatment: pulmonary alveolar microlithiasis. Lung India 2019; 36 (06) 553-554
- 36 Ozcelik U, Yalcin E, Ariyurek M. et al. Long-term results of disodium etidronate treatment in pulmonary alveolar microlithiasis. Pediatr Pulmonol 2010; 45 (05) 514-517
- 37 Emiralioglu N, Beken B, Ozcan HN. et al. Diagnosis and treatment of pulmonary alveolar microlithiasis. Pediatr Int 2016; 58 (08) 805-807
- 38 Cakir E, Gedik AH, Özdemir A, Buyukpınarbasili N, Bilgin M, Ozgen IT. Response to disodium etidronate treatment in three siblings with pulmonary alveolar microlithiasis. Respiration 2015; 89 (06) 583-586
- 39 Azim S, Azim W, Hayat FShafi H. Treatment of pulmonary alveolar microlithiasis with allendronate sodium. Biomedica 2004; 20: 32-35
- 40 Mardani P, Naseri R, Shahriarirad R. et al. Successful bilateral lung transplantation in pulmonary alveolar microlithiasis: a case report and review of literature. Clin Respir J 2024; 18 (05) e13773
- 41 Pracyk JB, Simonson SG, Young SL, Ghio AJ, Roggli VL, Piantadosi CA. Composition of lung lavage in pulmonary alveolar microlithiasis. Respiration 1996; 63 (04) 254-260
- 42 Kumar P, Jindal A, Dutta P, Attawar S, Rahulan V. Anaesthetic challenges in pulmonary alveolar microlithiasis—a rare disease treated with bilateral lung transplantation, first case from India. Ann Card Anaesth 2021; 24 (01) 79-82
- 43 Matta A, Polychronopoulou E, Kuo YF, Sharma G, Duarte AG. Pulmonary rehabilitation utilization in patients with chronic respiratory diseases: 2014-2019. Respir Med 2025; 242: 108110
- 44 Ren XY, Fang XM, Chen JY. et al. Single-lung transplantation for pulmonary alveolar microlithiasis: a case report. World J Clin Cases 2019; 7 (22) 3851-3858
- 45 Alrossais NM, Alshammari AM, Alrayes AM. et al. Pulmonary hypertension and polycythemia secondary to pulmonary alveolar microlithiasis treated with sequential bilateral lung transplant: a case study and literature review. Am J Case Rep 2019; 20: 1114-1119
- 46 Bisson A, Bonnette P. A new technique for double lung transplantation. “Bilateral single lung” transplantation. J Thorac Cardiovasc Surg 1992; 103 (01) 40-46
- 47 Stamatis G, Zerkowski HR, Doetsch N, Greschuchna D, Konietzko N, Reidemeister JC. Sequential bilateral lung transplantation for pulmonary alveolar microlithiasis. Ann Thorac Surg 1993; 56 (04) 972-975
- 48 Jackson KB, Modry DL, Halenar J, L'abbe J, Winton TL, Lien DC. Single lung transplantation for pulmonary alveolar microlithiasis. J Heart Lung Transplant 2001; 20 (02) 226
- 49 Samano MN, Waisberg DR, Canzian M, Campos SV, Pêgo-Fernandes PM, Jatene FB. Lung transplantation for pulmonary alveolar microlithiasis: a case report. Clinics (Sao Paulo) 2010; 65 (02) 233-236
- 50 Güçyetmez B, Ogan A, Cimet Ayyıldız A, Yalçın Güder B, Klepetko W. Lung transplantation in an intensive care patient with pulmonary alveolar microlithiasis—a case report. F1000 Res 2014; 3: 118
- 51 Hashim MY, Yousef YR, Alkattan KY, Abdulqawi RY, Migliore MY, Saleh W. Lung transplantation outcomes of patients with pulmonary alveolar microlithiasis the largest series from a single centre experience. J Heart Lung Transplant 2024; 43 (04) S443-S444
- 52 Hoeper MM, Humbert M, Souza R. et al. A global view of pulmonary hypertension. Lancet Respir Med 2016; 4 (04) 306-322
- 53 Humbert M, Kovacs G, Hoeper MM. et al; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2023; 61 (01) 2200879
- 54 Nathan SD, Barbera JA, Gaine SP. et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J 2019; 53 (01) 1801914
- 55 Whelan TP, Dunitz JM, Kelly RF. et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant 2005; 24 (09) 1269-1274
- 56 Synetos A, Dilaveris P, Gialafos E, Giannopoulos G, Stefanadis C. Severe pulmonary hypertension due to pulmonary alveolar microlithiasis. Int J Cardiol 2006; 106 (03) 396-397
- 57 Yetkin O. Pulmonary alveolar microlithiasis: a rare cause of severe pulmonary hypertension. Int J Cardiol 2007; 118 (01) 133-134 , author reply 132
- 58 Nakshbandi G, Moor CC, Wijsenbeek MS. Role of the internet of medical things in care for patients with interstitial lung disease. Curr Opin Pulm Med 2023; 29 (04) 285-292
- 59 Althobiani M, Alqahtani JS, Hurst JR, Russell AM, Porter J. Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians. BMJ Open Respir Res 2021; 8 (01) e001088
- 60 Wijsenbeek MS, Moor CC, Johannson KA. et al. Home monitoring in interstitial lung diseases. Lancet Respir Med 2023; 11 (01) 97-110
- 61 Çetin N, Olcay SS, Tapan U, Çetinkaya PD, McCormack FX, Altınışık G. Considering patient perspective through visual representatives: telemedicine gives voice to rare interstitial lung disease patients. Thorac Res Pract 2025; 26 (04) 208-210